Two related glycoproteins (G and GNs ) encoded in the bovine ephemeral fever virus (BEFV) genome were expressed from recombinant vaccinia viruses (rVV). Both proteins were detected in lysates of rVV-infected cells by labelling with D-[6-3H]glucosamine or by immuno-blotting. The recombinant G protein (mol. mass 79 kDa) appeared slightly smaller than the native G protein but reacted with monoclonal antibodies directed against all defined neutralizing antigenic sites (G1, G2, G3a, G3b and G4). The recombinant G~s protein (mol. mass 90 kDa) was identical in size to the native GNs protein and failed to react by immunofluorescence with anti-G protein monoclonal or polyclonal antibodies. Antisera raised in rabbits against rVV-G or rVV-GNs both reacted strongly by immunofluorescence and immuno-electron microscopy with BEFV-infected cells. The G protein was localized intracellularly in the endoplasmic reticulum/Golgi complex and at the cell surface associated with budding and mature virus particles. The GNs protein also localized intracellularly in the endoplasmic reticulum/Golgi complex; however, at the cell surface it was associated with amorphous structures and not with budding or mature virions. Rabbits vaccinated with rVV-G developed high levels of antibodies which neutralized BEFV grown in either mammalian or insect cells. Cattle vaccinated with rVV-G also produced neutralizing antibodies and were protected against experimental BEFV infection. In contrast, rW-GNs vaccinated rabbits and cattle failed to produce neutralizing antibodies and, after challenge, BEFV was isolated from two-thirds of the vaccinated cattle.
Introduction
Bovine ephemeral fever virus (BEFV) is an arthropodborne rhabdovirus, genus Ephemerovirus (Wunner et al., 1995) , which causes an acute febrile disease in cattle and water buffalo. In tropical and sub-tropical regions of Africa, Asia and Australia, seasonal epidemics can have significant economic consequences. The BEFV virion has the characteristics typical of rhabdoviruses with bulletshaped morphology, a single-stranded ( -) RNA genome, a lipid envelope and five structural proteins designated L, G, N, M 1 and M2 (Della-Porta & Brown, 1979; Walker et al., 1991) . The virion G protein is an 81 kDa transmembrane glycoprotein which contains type-specific, neutralizing antigenic sites (Cybinski et al., 1990; Walker et al., 1991) . Vaccination of cattle with G * Author for correspondence. Fax + 61 52 275-555. protein purified from BEFV virions induces neutralizing antibodies and protects against subsequent experimental infection (Uren et al., 1994) . However, unlike other rhabdoviruses, the genomes of BEFV and the closely related Adelaide River virus (ARV) encode a second glycoprotein gene (GNs) which is located immediately downstream of the G gene. The 90 kDa BEFV Gz~s protein is a highly glycosylated product which is related in structure and amino acid sequence to G protein and appears to have arisen by gene duplication Wang & Walker, 1993) . The GNs protein is present in infected cells in similar abundance to the G protein but has not been detected in virions and its function is presently unknown (Walker et al., 1991) .
In this paper, we report the construction and analysis of recombinant vaccinia viruses (rVV) which express the BEFV G or G•s proteins. We show that native G protein is transported to the surface of BEFV-infected cells via the endoplasmic reticulum/Golgi complex, is associated with budding and mature virus particles and that 0001-3640 © 1996 SGM 
Methods
Viruses and cells. BEFV strain BB7721 was isolated from a cow with clinical bovine ephemeral fever (Doherty et al., 1969) . The passage history and growth of the virus in BHK-21 cells (BSR clone) have been described (Walker et aL, 1991) . The challenge virus used in vaccination experiments was isolated from the same source and had been passaged only 11 times in cattle (Uren et al., 1994) . BEFV strain CSIRO 1927 was isolated from the blood of an infected cow at Kairi, Queensland, Australia in 1975 and had been passaged only three times in insect cells. Aedes albopictus cells (clone C6/36) were grown in Leibovitz L-15 medium containing 10% fetal calf serum (FCS) and 5 % tryptose phosphate broth as described previously (Uren et aL, 1992) . Vaccinia virus strain NYBH (VV-NYBH) was used as parental virus for the construction of recombinant vaccinia viruses (rVV) and as control virus. The viruses were grown in human TK-143B cells in Eagle's minimal essential medium containing 5 % FCS.
Construction of recombinant vaccinia viruses.
DNA manipulations were performed according to standard procedures. BEFV G and GNs genes were amplified from genomic cDNA clone g207 by PCR using synthetic oligonucleotide primer pairs GI.IB (5' GGCCAGATCTACAATGTTCAAGGTCCTCATA-ATT 3')/ G1.2B (5 ' GGCCAGATCTTTAATGATCAAAGAACCTATCA-TCACCAG 3 ') and G2.1AB (5' GGCCGGATCCATCATGTTCCT-GCAACT-ATTTAATATCG 3")/G2.2AB (5 ~ GGCCGGATCCGCT-CAATAATCCAA-CTTAAAG 3') respectively. The PCR products were cloned into the Sinai site of plasmid pUCI8 and then subcloned into the BamHI site of VV transfer vector pFN24 in which the VV thymidine kinase gene is interrupted by a fowlpox early-late promoter (PEru) and a multiple cloning site (H. G. Heine and others, unpublished). The G gene was subcloned as a BglII fragment derived from clone G1.A6 and the GNs gene as a BamHI fragment from clone G2.H4, placing both genes in frame with the ATG ofPE/L. Human TK-143B cells infected with VV strain NYBH were used to construct rVVs by homologous recombination as described previously (Boyle et al., 1985) . rVVs were plaque purified three times in 143B cells. Recombinants were identified by blue/white selection in the presence of X-Gal due to co-expression of fl-galactosidase (Chakrabarti et aL, 1985) .
Glueosamine labelling. Confluent monolayers of BHK cells in 24-well plates were infected with BEFV or VV at a multiplicity of 20 p.f.u./cell. At 10 h post-infection (VV) or 25 h post-infection (BEFV), infected cells were washed once with PBS and then incubated for 2 h in glucosefree RPMI 1640 (Gibco BRL) supplemented with 10 mM-HEPES, 100 U/ml penicillin, 100 ~tg/ml streptomycin and 10% bovine serum albumin Fraction V (BSA). After glucose starvation, 200 gCi/ml D-[6-3Hlglucosamine hydrochloride (Amersham) was added. After 2 h, the cells were washed twice with PBS and harvested into 50 gl of SDS gel loading buffer (50mM-Tris-HC1, pH6.8, 10% (v/v) glycerol, 2% (w/v) SDS, 0'1% (w/v) bromophenol blue, 100 mM-DTT). Radiolabelled proteins were analysed by electrophoresis in 12% SDSpolyacrylamide gels and fluorography (Walker et al., 1991) .
Protein immunoblotting. Confluent monolayers of BHK cells grown in 25 cm 2 flasks were infected with BEFV or VV at a multiplicity of 10p.f.u./cell. At 12 h post-infection (VV) or 36h post-infection (BEFV), infected cells were washed twice with PBS and harvested into 10 gl of SDS gel loading buffer. The proteins were resolved by electrophoresis in 12% SDS-polyacrylamide gels and transferred to nitrocellulose membranes (Schleicher and Schuell) by electroblotting. The membranes were blocked with 5 % non-fat dry milk in 0-02 % Tween 20 in PBS, incubated for 1 h with BEFV G protein monoclonal antibody 17B t or rabbit antiserum diluted in blocking solutior~, washed three times, incubated with sheep anti-mouse or sheep anti-rabbit IgG conjugated with horseradish peroxidase (Silenus), washed three times and reacted with 4-chloro-l-naphthol and hydrogen peroxide.
Immunofluorescence assays. Confluent monolayers of BHK cells in Lab-Tek tissue culture chamber slides (Miles Scientific) were infected at a multiplicity of 1 p.f.u./cell with BEFV or VV. At 10 h post-infection (VV) or 24 h post-infection (BEFV), cells were treated with BEFV G protein monoclonal antibody (diluted 1:500 to 1:2000 in PBS) or rabbit antiserum (diluted 1:100 in PBS). For total cell staining, cells were fixed in methanol prior to antibody treatment. For cell surface staining, primary antibodies were added directly to the culture medium for 30rain at 37 °C and the cells were subsequently fixed with methanol. Binding of specific antibodies was detected with fluorescein isothiocyanate-conjugated sheep anti-mouse or sheep anti-rabbit IgG (Silenus).
Immunization of rabbits. Seven I2 to 16-week-old Half Lop rabbits were vaccinated by scarification on days 1 and 21 respectively. Blood samples were collected on days 0, 21 and 49. Three rabbits each were vaccinated with rVV-G or rVV-Gss and one rabbit with VV-NYBH as control.
Immunization and challenge of cattle. Six-month-old Hereford cattle were vaccinated intradermally on days 1 and 15. Six were vaccinated with rVV-G, six with rVV-GNs, three with a combination of rVV-G and rVV-G~s and three with VV-NYBH. On day 29 all cattle were challenged with 5 ml of blood from a BEFV-infected cow (104"~ TCIDso/ml). Blood samples were collected prior to vaccination, revaccination and challenge (days 0, 15 and 29), twice daily for 10 days and on days 39 and 45 after challenge. Bufl3, coat fractions were prepared for virus isolation and sera were tested for anti-viral antibodies.
Blocking ELISA and virus neutralization assays. The blocking ELISA was performed according to the method of Zakrzewski et aL (1992) using BEFV G protein monoclonal antibody DB5. Virus neutralization tests in BHK cells were done according to the method of Cybinski et aL (1978) using BEFV strain BB7721. Virus neutralization tests in Aedes albopictus cells were done using BEFV strain CSIRO 1927 according to the method described by Cybinski et aL (1992) .
Virus isolation. Viruses were isolated as described by Uren et al. (1992) . Briefly, 200 gl of bully coat was added to medium containing Aedes albopictus cells, transferred to 25 cm 2 tissue culture flasks and incubated at 28 °C for 12 to 14 days. The cells were dispersed into suspension, 50 lal transferred to 96-well flat-bottomed tissue culture plates and incubated at 37 °C for 24 h. The medium was removed and the cells were fixed with 50% acetone in PBS for 15 min and air dried. The cells were examined for BEFV antigens by immunofluorescence as described by Cybinski & Zakrzewski (1983) . This test determines the presence or absence of virus (it does not determine the titre of virus). 
Conventional and immuno-electron m&roscopy. Uninfected and
BEFV-infected BHK cells were processed for conventional ultra-thin sections, pre-embedding immuno-electron microscopy and for the generation of cryo-sections. Preparations for conventional electron microscopy were fixed (40 rain) with 2"5 % (v/v) gluteraldehyde buffered with 0.1 M-cacodylate buffer (pH 7-2, 300 mM-OsO4) washed in the same buffer (3 x 20 rain), post-fixed in 1% (w/v) osmium tetroxide (1 h), washed in water (4 x 5 rain), dehydrated through graded alcohol and embedded in Spurr's low viscosity resin. Pre-immuno embedding electron microscopy was performed as described by Hyatt (1991) . Briefly, infected cells were fixed with 0.1% (v/v) glutaraldehyde (10 rain) and incubated for 1 h at room temperature with a 1 : 625 dilution of rabbit anti-G or G~s (diluted with 1% cold water fish gelatine in PBS-wash buffer). After six rinses in wash buffer the cells were incubated with a 1:40 dilution of 9 nm gold-labelled goat anti-rabbit (Amersham) for 1 h (room temperature). Cells were then rinsed (six times) and processed as described by Hyatt (1991) .
For cryo-sectioning, uninfected and infected cells were fixed as described for pre-embedding immuno-electron microscopy. After six rinses in wash buffer, cells were scraped and pelleted in 5 % gelatine. The resulting pellets were fixed for a further 10 rain in 0-1% (v/v) gluteraldehyde, rinsed in wash buffer and infiltrated with 2.3 Msucrose-t0 % polyvinylpyrrolidone. Cryo-sections were incubated with the above antibodies and processed as described by Hyatt & Wise (1994) .
Results

Identification of rVV-expressed BEFV G and Gxs proteins
B H K cells were infected with BEFV, vaccinia virus (VV-N Y B H ) or recombinant vaccinia viruses in which the BEFV G gene (rVV-G) or GNs gene (rVV-Gz, s) were expressed under the control of a fowlpox early-late promoter. At 12 h post-infection (VV) or 27 h postinfection (BEFV), cells were labelled for 2 h with D-[6-:~H]glucosamine hydrochloride and cell lysates were analysed by S D S -P A G E and fluorography (Fig. 1 A) . As described previously (Walker et al., 1991) , the 81 k D a B E F V G protein and 90 k D a B E F V G~s protein were detected in BEFV-infected cells. In rVV-G-infected cells, only one band o f similar mobility to the B E F V G protein was visible. In rVV-G~s-infected cells, a 90 k D a band corresponding to BEFV G~s protein was detected. However, a band o f similar mobility to the B E F V G protein was also detected and this also occurred in VV-NYBH-infected cells, suggesting co-migration of the BEFV G protein with a VV glycoprotein. To verify this, immunoblots were done on lysates prepared from cells infected with BEFV, V V -N Y B H , rVV-G or rVV-Gz~ s, using BEFV G protein monoclonal antibody 17BI (Fig.  1 B) . The results indicated that the G protein was present only in lysates of B E F V and rVV-G-infected cells and the recombinant G protein (mol. mass 79 kDa) appeared slightly smaller than the native form.
Antigenic analysis and cellular localization of BEFV G and GNs proteins
B H K cells infected with rVV-G, rVV-GNs or V V -N Y B H were examined by immunofluorescence microscopy for reactions with BEFV G protein using monoclonal antibodies directed against all defined neutralizing antigenic sites (Gt, G2, G3a, G3b and G4) (Cybinski et al., 1990 . As shown in Fig. 2 for representative epitopes, all monoclonal antibodies to G protein reacted with rVV-G-infected cells, indicating that the native antigenic structure was preserved in the recombinant protein.
Immunofluorescence was detected at the cell surface where the G protein appeared to accumulate in intensely staining patches (Fig. 2 A -E ) and in the cytoplasm (Fig. 2 F-J) , indicating that the recombinant G protein was anchored in the cell membrane and transported efficiently from the endoplasmic reticulum/ Golgi complex to the cell surface, In contrast, all B E F V G protein-specific monoclonal antibodies did not stain rVV-Gss-infected cells (Fig. 2 K -O ) . A polyclonal rabbit (640) 707 (640) Rabbits were vaccinated with rVV-G, rVV-GNs or VV-N Y B H and revaccinated after 21 days. Sera collected on day 0 (we-bleed), and on days 21 and 49 after initial infection were tested for virus-neutralizing antibodies.
Vaccimla virus-expressed B E F V glycoproteins
Neutralization tests were done in B H K cells and in Aedes albopictus cells using, respectively, homologous BB7721 strain adapted to B H K cells and C S I R O 1927 strain passaged only in Aedes albopictus cells after isolation from an infected cow (Table 1) . Three rabbits vaccinated with rVV-G developed neutralizing antibodies after the first vaccination and serum antibody titres increased after the second vaccination. Neutralization titres were similar for viruses grown in mammalian and insect cells. In contrast, rabbits vaccinated with rVV-GNs or VV-N Y B H did not develop antibodies that neutralized B E F V grown in either celt line (Table 1 ).
BEFV-infected B H K cells were examined by immunofluorescence for reactions with rVV-G, rVV-G~s or VV-N Y B H rabbit antisera. As observed for rVV-G-infected cells, the B E F V G protein was detected in the endoplasmic reticulum/Golgi (Fig. 3A) and on the cell surface (Fig. 3B) where it accumulated in intensely staining patches. In contrast, BEFV GNS protein was detected in the endoplasmic reticulum/Golgi (Fig. 3 C) but at the surface the staining was diffuse, apparently not associated with the intensely staining patches observed for G protein, V V -N Y B H rabbit antiserum failed to react with BEFV-infected B H K cells (data not shown).
Electron microscopic examination o f BEFV-infected B H K cells showed characteristic bullet-shaped particles budding from the plasma membrane. When these were incubated with rabbit anti-G antiserum the viruses were specifically gold-labelled; the adjacent areas of the plasma membrane were not gold-labelled (Fig 4A) . In contrast, when infected cells were incubated with rabbit anti-G~s antiserum, the gold-labelling was associated with a m o r p h o u s matrix on the extracellular aspect o f the plasma membrane and not with budding or mature virions (Fig. 4B) . Underlying the plasma membrane at the sites of Gxs localization were smooth-surfaced vesicles (Fig. 4B) . Labelling ofcryo-sections with anti-G or anti-G•s antisera showed intracellular gold-labelling to be associated with the juxta-nuclear smooth-surthced vesicles (Fig. 5A) . Examination o f similar regions within conventionally fixed cells (Fig 5B) showed that these structures are associated with the endoplasmic Fig. 2 . Immunofluorescence staining of rVV-infected BHK cells, rVV-G-infected cells were prepared for cell surface (panels A-E) or total (panels F--J) staining, and rVV-GNs-infected cells were prepared for total cellular staining only (panels K-O). Monoclonal antibodies: 17B1 (site G1; panels A, F and K); 12A5 (site G2; panels B, G and L); 3D6 (site G3a; panels C, H and M); 16A6 (site G3b; panels D, I and N) and 5A5 (site G4; panels E, J and O). Monoclonal antibodies were described by Cybinski et aL (1990 Cybinski et aL ( , 1992 
Vaccination of cattle with rVV-G and rVV-GNs viruses
The role of BEFV G and G~s glycoproteins in the induction of protective immunity was determined by vaccination of cattle twice at an interval of 2 weeks with rVV-G, rVV-GNs, rVV-G and rVV-G~ s or VV-NYBH, and challenge 2 weeks later with blood from a BEFVinfected cow. Cattle vaccinated with rVV-G alone or in combination with rVV-GNs developed neutralizing and blocking ELISA antibodies which continued to rise after the second vaccination and challenge (Fig. 6) . Viraemia was not detected in these animals for 10 days nor on day 16 after challenge. Cattle vaccinated with rVV-GNs alone or VV-NYBH did not develop neutralizing antibodies following vaccination but seroconverted after challenge. BEFV was isolated from blood samples collected from four of six cattle vaccinated with rVV-GNs and from two of three cattle vaccinated with YW-NYBH. In each case, virus was isolated between days 3 to 6 after challenge and, in three animals, virus was isolated on two to three consecutive days.
Discussion
Rhabdoviruses of the genus Ephemerovirus have the unusual characteristic of consecutive genes encoding related class 1 transmembrane glycoproteins. The BEFV G protein, like those of vesicular stomatitis virus and rabies virus, is a structural component of the viral envelope (Walker et al., 1991) which contains virusneutralizing antigenic sites (Cybinski et al., 1990) and induces protective immunity in cattle (Uren et al., 1994) . The BEFV GNs protein contains corresponding signal and transmembrane domains, and shares regions of significant amino acid sequence similarity with the virion G proteins of BEFV and other rhabdoviruses ). The Gz~ s protein is expressed in mammalian cells at similar levels to the G protein but, although it has the structural characteristics of a rhabdovirus envelope glycoprotein, it has not been detected in virions (Walker et al., 1991) . The results reported here indicate that, despite their structural similarity, the BEFV G and G~s proteins are antigenically unrelated and functionally distinct. Recombinant G~s protein failed to bind polyclonal BEFV G antiserum or monoclonal antibodies directed at each of the five G protein neutralization sites and did not induce neutralizing antibody or protective immunity in cattle. Anti-G~s rabbit serum also failed to neutralize BEFV grown in BHK or Aedes albopictus cells indicating that, at least in these cell lines, G~s does not function as a cell attachment protein.
Other families of negative-strand RNA viruses (paramyxoviruses, filoviruses, bunyaviruses, arenaviruses and orthomyxoviruses) possess two transmembrane glycoproteins that are packaged into the viral envelope. In bunyaviruses, both G1 and G2 are class 1 membrane proteins and, when co-expressed, both are retained in the Golgi complex (Chen et al., 1991 ; Ruusala et al., 1992) where virus maturation occurs. For the bunyavirus La Crosse, it has been proposed that the G1 and G2 glycoproteins have differential roles in vertebrate and insect cell attachment during natural infections (Ludwig et al., 1989) . We have tbund that in BEFV both G and G~s are transported via the endoplasmic reticulum/Golgi to the plasma membrane but only the G protein is packaged into mature virions. The signals responsible for the packaging of BEFV G protein whilst excluding G~s from mature virions have not been characterized. Although antiserum to G~s failed to neutralize BEFV in either vertebrate or invertebrate cell cultures, G~s may play a rote in extending BEFV cell tropism if packaged into mature virions in other tissues during natural infections.
Like the native G protein, rVV-expressed BEFV G effectively protected cattle against experimental infection. The recombinant G protein appeared slightly smaller than the native protein, perhaps due to the absence of N-glycosylation at one of the five potential sites. Despite its reduced size, the recombinant G protein retained the native antigenic structure, reacting with monoclonal antibodies representing all five defined neutralizing antigenic sites and was efficiently trans- The large open arrow shows the presence of gold particles with an amorphous matrix associated with the plasma membrane. This region of the plasma membrane was associated with large numbers of vesicles. Plasma membrane not associated with the amorphous matrix (thin arrow) was not gold-labelled. N, nucleus; C, cell. Bars represent 100 rim. reticulum/Golgi system. No gold labelling was observed on or within control cells reacted with antiserum to G or G~s. These results are consistent with an active involvement of the endoplasmic reticulum/Golgi system in the synthesis and transport of BEFV G and G~. s glycoproteins to the cell surface.
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Discussion
Like the native G protein, rVV-expressed BEFV G effectively protected cattle against experimental infection. The recombinant G protein appeared slightly smaller than the native protein, perhaps due to the absence of N-glycosylation at one of the five potential sites. Despite its reduced size, the recombinant G protein retained the native antigenic structure, reacting with monoclonal antibodies representing all five defined neutralizing antigenic sites and was efficiently trans- The large open arrow shows the presence of gold particles with an amorphous matrix associated with the plasma membrane. This region of the plasma membrane was associated with large numbers of vesicles. Plasma membrane not associated with the amorphous matrix (thin arrow) was not gold-labelled. N, nucleus; C, cell. Bars represent 100 rim. ported to the ceil surface. The r e c o m b i n a n t GNs protein was indistinguishable in size from the highly glycosylated native protein. A l t h o u g h GNs failed to protect against challenge with BEFV-infected cattle blood, its role in infection requires further investigation and challenge experiments using infected insects will be required to exclude totally its possible involvement in protection. The efficacy of current live attenuated or live-killed B E F V vaccines has, in general, been less t h a n satisfactory ( U r e n et al., 1992, 1994) . This study suggests that r e c o m b i n a n t glycoproteins expressed by VV, other viral vectors or naked D N A may be useful alternatives to current vaccines.
